# OnCo record prostate-ductal-adenocarcinoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/prostate-ductal-adenocarcinoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "prostate-ductal-adenocarcinoma" ;
  schema:name "Ductal adenocarcinoma of the prostate"@en ;
  schema:alternateName "Prostatic ductal adenocarcinoma"@en, "Ductal adenocarcinoma"@en, "Ductal prostate cancer"@en, "Adenocarcinoma with ductal features"@en, "Mixed acinar-ductal adenocarcinoma"@en, "Endometrioid carcinoma of the prostate"@en, "DAC"@en ;
  schema:description "Ductal adenocarcinoma is a rare type of prostate cancer, roughly one case in six hundred, that grows from the larger ducts of the gland rather than from its small acini. It tends to make less PSA than ordinary prostate cancer, so it is found later and more often after it has spread, and it is treated as high-risk disease from the day it is named."@en ;
  schema:url <https://onco.cc/cancers/prostate-ductal-adenocarcinoma/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Prostate_cancer> ;
  schema:citation <https://doi.org/10.1002/bco2.60>, <https://doi.org/10.1111/his.14711>, <https://tumourclassification.iarc.who.int/chapters/36>, <https://www.rcpath.org/static/8cc88604-2c8d-4df4-a99542df41c102af/G084-dataset-for-histopathology-reports-for-prostatic-carcinoma.pdf>, <https://pubmed.ncbi.nlm.nih.gov/35965208/> ;
  onco:tag "gu", "subtype-page" ;
  onco:related <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-nepc/>, <https://onco.cc/cancers/prostate-high-risk/>, <https://onco.cc/cancers/prostate-mhspc/> ;
  onco:technologies <https://onco.cc/technologies/mp-mri/>, <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/technologies/histopathology-ihc/> ;
  onco:terms <https://onco.cc/terms/gleason-grade-group/>, <https://onco.cc/terms/intraductal-carcinoma-prostate/>, <https://onco.cc/terms/cribriform-prostate-cancer/>, <https://onco.cc/terms/psa/>, <https://onco.cc/terms/prostate-acinar-adenocarcinoma/>, <https://onco.cc/terms/tnm-prostate-cancer/>, <https://onco.cc/terms/cambridge-prognostic-group/> ;
  onco:standardOfCare <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/androgen-deprivation/>, <https://onco.cc/terms/prostatectomy/>, <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/terms/intraductal-carcinoma-prostate/>, <https://onco.cc/terms/cribriform-prostate-cancer/>, <https://onco.cc/technologies/androgen-deprivation/>, <https://onco.cc/technologies/psma-pet/> .
